格林美(002340.SZ):聘任董事長許開華兼任公司總經理
格隆匯6月1日丨格林美(002340.SZ)公佈,近日收到總經理蔣振康提交的書面辭職報告,蔣振康由於個人原因申請辭去總經理職務,辭職後其不再擔任公司任何職務。蔣振康的辭職報告自送達公司董事會時生效。公司及公司董事會對蔣振康先生在任職期間為公司的發展所做的辛勤工作表示感謝。
公司於2020年6月1日召開了第五屆董事會第十五次會議,審議通過了《關於聘任公司總經理的議案》。經公司董事會提名委員會提名審查,同意聘任董事長許開華兼任公司總經理職務,任期自本次董事會審議通過之日起至第五屆董事會任期屆滿日止。公司獨立董事已就上述事項發表了同意的獨立意見。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.